Clearmind reports safety and reduced alcohol consumption with combination of MEAI and CannAmide May 25, 2022
One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia Nov. 22, 2021
New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome Nov. 4, 2021
RSS